#United States #New York #NavaDerm #LSSCNY #Dr. Bernstein

In an exciting development for the field of dermatology, NavaDerm Partners, LLC has officially announced the appointment of Dr. Leonard Bernstein as the new medical director of the Laser Skin Surgery Center of New York (LSSCNY). This strategic move is part of a broader initiative aimed at solidifying the clinic's leadership position in both medical and cosmetic dermatology. Dr. Bernstein is not only a board-certified dermatologist but also an accomplished Mohs surgeon. His background is impressive; he holds a Bachelor of Arts degree in Chemistry from Northwestern University College of Arts and Sciences as well as a Medical Degree from the Northwestern University School of Medicine. Following this, he completed his dermatology residency at Northwestern Memorial Hospital, where he served as chief resident and further honed his expertise during a fellowship in Mohs Micrographic Surgery and laser technology at the Laser Skin Surgery Center of New York. Beyond his clinical skills, Dr. Bernstein is an Assistant Clinical Professor of Dermatology at New York Hospital/Cornell Medical Center, showcasing his commitment to education in the medical field. He is associated with the Department of Plastic Surgery/Dermatology at Mount Sinai Hospital and the New York Eye and Ear Infirmary. Throughout his career, Dr. Bernstein has gained recognition as a Fellow of various prestigious organizations including the American Academy of Dermatology and the American Society of Lasers in Medicine and Surgery. His contributions to the field include authoring numerous research articles and book chapters focusing on laser and surgical techniques. The announcement also highlighted the establishment of a Clinical Advisory Board for LSSCNY, which is aimed at ensuring the continuity of innovative treatments in skin health care. This board will consist of board-certified dermatologists with extensive experience in both medical and cosmetic dermatology. Members include renowned professionals such as Dr. Robert Anolik, Dr. Yoon-Soo ('Cindy') Bae, Dr. Roy Seidenberg, and Dr. Ronald Shelton, who will work alongside Dr. Bernstein to guide the center's strategic clinical direction. Dr. Cindy Bae expressed her enthusiasm for this collaboration, stating that she looks forward to working with Dr. Bernstein to strengthen LSSCNY's authoritative stance in the dermatological community. Inder Tallur, Chairman of NavaDerm, addressed the appointment, acknowledging the importance of having distinguished physicians like Dr. Bernstein leading their initiatives in the growing dermatology sector. He praised Dr. Geronemus, who has contributed immensely over his 31-year tenure at LSSCNY, wishing him well in his future endeavors. Dr. Bernstein himself expressed his gratitude for this opportunity, highlighting the commitment of LSSCNY and NavaDerm to uphold a reputation for innovation. He looks forward to uniting his expertise with those of his new colleagues to ensure high-quality care for patients traveling to LSSCNY from across the United States and around the globe. For many years, the Laser Skin Surgery Center of New York has been recognized as a premier institution in cosmetic and general dermatology, dermatologic surgery, laser surgery, and Mohs surgery. With a robust roster of 12 physicians and two locations in New York City and Southampton, LSSCNY stands as one of the most significant dermatology groups in the nation, also functioning as a clinical research site with specialized knowledge in laser applications and a successful history of conducting clinical trials. NavaDerm Partners, headquartered in New York City, strengthens this legacy as a comprehensive dermatology management platform, formed from collaborations among five dermatology groups throughout New York and New Jersey. With operations across seven locations, their mission is to empower their network of over 50 board-certified dermatologists in delivering exceptional patient care. BelHealth Investment Partners, the parent company of NavaDerm, is a private equity firm with a focus on the healthcare sector, driven by the intention to foster growth in middle-market companies. As these changes take place, both NavaDerm and LSSCNY look forward to continuing their commitment to providing cutting-edge dermatological services and enhancing the care experience for patients everywhere.